Document is current
Any future updates will be listed below
-
Authors
Mavrommatis, Christos
Belsky, Daniel W. https://orcid.org/0000-0001-5463-2212
Ying, Kejun
Moqri, Mahdi https://orcid.org/0000-0001-6675-0566
Campbell, Archie https://orcid.org/0000-0003-0198-5078
Richmond, Anne
Gladyshev, Vadim N. https://orcid.org/0000-0002-0372-7016
Chandra, Tamir https://orcid.org/0000-0002-7935-317X
McCartney, Daniel L.
Marioni, Riccardo E. https://orcid.org/0000-0003-4430-4260
-
Funding
Funding for this research was provided by:
Wellcome Trust (104036/Z/14/Z and 221890/Z/20/Z)
Chief Scientist Office (CZD/16/6)
Scottish Funding Council (HR03006)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG073402 and R01AG087158)
- License Information
-
More Information
Article History
Received: 29 July 2025
Accepted: 30 October 2025
First Online: 16 December 2025
Competing interests
: R.E.M. is an advisor to the Epigenetic Clock Development Foundation and Optima Partners Ltd. D.L.M. is employed by Optima Partners Ltd. D.W.B. is an inventor of DunedinPACE, which is licensed to TruDiagnostic. The remaining authors declare no competing interests.
